Case report details bridge to heart transplantation using a ventricular assist device in a tumor patient, suggesting life-saving potential.
This case report exemplifies how a ventricular assist device successfully supported a 15 year old tumor patient with anthracycline-induced cardiomyopathy for 419 days until she was confirmed free from tumor recurrence to undergo heart transplantation, presently with an 18 year follow up without any malignancy.
No takes yet. Share an insight, caveat, or question.
Javier et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: